Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Accumulated Expenses: 2023-2024

  • Camp4 Therapeutics' Other Accumulated Expenses was N/A to $369,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $369,000, marking a year-over-year change of. This contributed to the annual value of $289,000 for FY2023, which is N/A change from last year.
  • Camp4 Therapeutics' Other Accumulated Expenses amounted to $369,000 in Q3 2024, which was up 27.68% from $289,000 recorded in Q4 2023.
  • In the past 5 years, Camp4 Therapeutics' Other Accumulated Expenses registered a high of $369,000 during Q3 2024, and its lowest value of $289,000 during Q4 2023.
  • Its 2-year average for Other Accumulated Expenses is $329,000, with a median of $329,000 in 2023.